期刊文献+

孕产妇不规则抗体筛选结果分析 被引量:6

Analysis of maternal irregular antibody screening results
原文传递
导出
摘要 目的:研究孕产妇血清中不规则抗体检出的几率,探讨孕产妇不规则抗体对输血的影响以及对孕产妇不规则抗体检测的必要性。方法:对本地区17家医疗机构自2009-2012年3年的孕产妇3 654人次,用试管法、微柱凝胶法进行不规则抗体检查和确认,并与3783人次随机无偿献血者的血样进行对比。结果:孕产妇血清不规则抗体阳性率为1.18%,明显高于普通献血者的0.33%(P<0.05)。其中E抗体的阳性率为0.65%(24人次),C抗体的阳性率为0.33%(12人次),其他抗体的阳性率为0.18%(7人次),而普通献血者的相应抗体的阳性率分别为0.19%(7人次)、0.11%(4人次)、0.03%(3人次),均差异有统计学意义(均P<0.05)。结论:孕产妇作为受血者发生输血反应的几率比较高,输血时必须开展不规则抗体筛查,必要时做RhE、RhC同型输注。 Objective:To study the risk of maternal serum in irregular antibody detection,and explore the effect of irregular antibodies on maternal blood transfusion and the necessity of maternal irregular antibody detection. Method:Irregular antibody of maternal person-time from 3 65417 local medical institutions since 2009--2012 was tested and verified by tube method and microcolumn gel method,and the results were compared with that of 3 783 person time random blood donors. Result:The maternal serum irregular antibody positive rate of 1.18% was sig nificantly higher than that of normal blood donors,0.33%. The E antibody positive rate was 0.65% (24) ,C anti- body positive rate was 0. 33% (12 times) ,the positive rate of antibody to the other was 0.18% (7 times) ,the pos itive rate of antibodies and normal blood donors were 0. 19% (7 people),0. 11% (4),0.03% (3 people). There were significant differences (P〈0. 05). Conclusion: The incidence of transfusion reaction for pregnant women as recipients would be relatively high, so they must carry out the irregular antibody screening before blood transfu- sion. It is necessary to do the RhE and RhC homotypic infusion.
出处 《临床血液学杂志(输血与检验)》 CAS 2013年第5期723-724,共2页 Journal of Clinical Hematology(Blood Transfusion & Laboratory Medicine)
关键词 孕产妇 输血 不规则抗体 筛查 maternal blood transfusion irregular antibody screening
  • 相关文献

参考文献2

二级参考文献12

共引文献51

同被引文献47

  • 1吴远军,刘彦慧,刘兴玲,刘景春,吴勇,陈宝婵,梁燕.汉族患者(30800例)及孕妇(4200例)红细胞血型不规则抗体分布的调查[J].第四军医大学学报,2007,28(10):922-925. 被引量:57
  • 2肖星甫.抗体的检查与鉴定[A].输血技术手册[M],成都:四川科学技术出版社,1992:95—96.
  • 3中华人民共和国卫生部.临床输血技术规范(S].卫医发(2000)184.
  • 4Wu K H, Chu S L, Cluing J G, et al. Haemolytic disease of the newborn due to maternal irregular antibodies in the Chinese population in Taiwan [ J ]. Transfus Med, 2003, 13(5) : 311 -314.
  • 5Watchko J F. Identification of neonates at risk for hazardous hyperbilirubinemia: emerging clinical insights[J]. Pediatr Clin North Am, 2009, 56(3) : 671 -687.
  • 6Koelewijn J M, Vrijkotte T G, De Haas M, et al. Risk factors for the presence of non-rhesus D red blood cell antibodies in pregnancy[ J]. BJOG, 2009, 116(5) : 655 -664.
  • 7Winters J L, Pineda A A, Gorden L D, et al. RBC alloantibody specificity and antigen potency in Olmsted County, Minnesota[ J ]. Transfusion, 2001, 41(11) : 1413 -1420.
  • 8Takeshita A, Watanabe H, Fijihara H, et al. Collaborative study of irregular erythrocyte antibodies in Japan: results from the Japanese study group of allo-immunity and antigen diversity in Asian populions [J]. Transfus Apher Sci, 2010, 43(1) : 3 -8.
  • 9Duman D, Pilit F, Simsek E, et al. Serun caybohydrate antigen 125 levels in advanced heart failure: relation to B-type natyiuretic peptide and left volume[J]. Eur J Heart Fail, 2008, 10(6) : 556 -559.
  • 10陈静,马涛.微柱凝胶技术筛选及鉴定不规则抗体的临床应用[J].河北医药,2008,30(8):1233-1234. 被引量:8

引证文献6

二级引证文献98

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部